APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pulmonary Surfactant

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pulmonary Surfactant Industry Growth and Trends Forecast to 2032

23 December 2025118 pages

Choose your research edition.

Industry ResearchPulmonary Surfactant Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Pulmonary Surfactant Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Pulmonary Surfactant Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pulmonary Surfactant Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Pulmonary Surfactant Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Pulmonary Surfactant market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pulmonary Surfactant is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pulmonary Surfactant is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pulmonary Surfactant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pulmonary Surfactant include Abbott, Nanjing Norris Pharm Technology, AbbVie, XpressBio, Windtree Therapeutics, Tekzima (Noargen), Reddot Biotech, ONY Biotech and Lyomark Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pulmonary Surfactant market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pulmonary Surfactant market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pulmonary Surfactant market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pulmonary Surfactant.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pulmonary Surfactant market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pulmonary Surfactant Market by Company

Abbott

Nanjing Norris Pharm Technology

AbbVie

XpressBio

Windtree Therapeutics

Tekzima (Noargen)

Reddot Biotech

ONY Biotech

Lyomark Pharma

LSBio

Creative Diagnostics

Boehringer Ingelheim

Biorbyt

Biomatik

Aviva Systems Biology

Pulmonary Surfactant Segment by Type

Synthetic Pulmonary Surfactants

Animal Derived Surfactants

Pulmonary Surfactant Segment by Application

Hospital

laboratory

Others

Pulmonary Surfactant Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pulmonary Surfactant market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pulmonary Surfactant and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pulmonary Surfactant.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pulmonary Surfactant manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pulmonary Surfactant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Synthetic Pulmonary Surfactants Table 2. Major Company of Animal Derived Surfactants Table 3. Global Pulmonary Surfactant Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Pulmonary Surfactant Sales by Type (2021-2026) & (k units) Table 5. Global Pulmonary Surfactant Sales Market Share in Volume by Type (2021-2026) Table 6. Global Pulmonary Surfactant Sales by Type (2021-2026) & (US$ Million) Table 7. Global Pulmonary Surfactant Sales Market Share in Value by Type (2021-2026) Table 8. Global Pulmonary Surfactant Price by Type (2021-2026) & (US$/unit) Table 9. Global Pulmonary Surfactant Sales by Type (2027-2032) & (k units) Table 10. Global Pulmonary Surfactant Sales Market Share in Volume by Type (2027-2032) Table 11. Global Pulmonary Surfactant Sales by Type (2027-2032) & (US$ Million) Table 12. Global Pulmonary Surfactant Sales Market Share in Value by Type (2027-2032) Table 13. Global Pulmonary Surfactant Price by Type (2027-2032) & (US$/unit) Table 14. North America Pulmonary Surfactant Sales by Type (2021-2026) & (k units) Table 15. North America Pulmonary Surfactant Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Pulmonary Surfactant Sales by Type (2021-2026) & (k units) Table 17. Europe Pulmonary Surfactant Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Pulmonary Surfactant Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Pulmonary Surfactant Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Pulmonary Surfactant Sales by Type (2021-2026) & (k units) Table 21. Latin America Pulmonary Surfactant Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Pulmonary Surfactant Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Pulmonary Surfactant Sales by Type (2021-2026) & (US$ Million) Table 24. Pulmonary Surfactant Industry Trends Table 25. Pulmonary Surfactant Industry Drivers Table 26. Pulmonary Surfactant Industry Opportunities and Challenges Table 27. Pulmonary Surfactant Industry Restraints Table 28. Global Pulmonary Surfactant Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Pulmonary Surfactant Revenue Market Share by Company (2021-2026) Table 30. Global Pulmonary Surfactant Sales by Company (2021-2026) & (k units) Table 31. Global Pulmonary Surfactant Sales Share by Company (2021-2026) Table 32. Global Pulmonary Surfactant Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Pulmonary Surfactant Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Pulmonary Surfactant Major Company Production Sites and Headquarters Table 35. Global Pulmonary Surfactant Company, Product Type & Application Table 36. Global Pulmonary Surfactant Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Pulmonary Surfactant by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Pulmonary Surfactant Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Pulmonary Surfactant Sales by Region (2021-2026) & (k units) Table 41. Global Pulmonary Surfactant Sales Market Share in Volume by Region (2021-2026) Table 42. Global Pulmonary Surfactant Sales by Region (2021-2026) & (US$ Million) Table 43. Global Pulmonary Surfactant Sales Market Share in Value by Region (2021-2026) Table 44. Global Pulmonary Surfactant Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Pulmonary Surfactant Sales by Region (2027-2032) & (k units) Table 46. Global Pulmonary Surfactant Sales Market Share in Volume by Region (2027-2032) Table 47. Global Pulmonary Surfactant Sales by Region (2027-2032) & (US$ Million) Table 48. Global Pulmonary Surfactant Sales Market Share in Value by Region (2027-2032) Table 49. Global Pulmonary Surfactant Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Pulmonary Surfactant Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Pulmonary Surfactant Sales by Application (2021-2026) & (k units) Table 52. Global Pulmonary Surfactant Sales Market Share in Volume by Application (2021-2026) Table 53. Global Pulmonary Surfactant Sales by Application (2021-2026) & (US$ Million) Table 54. Global Pulmonary Surfactant Sales Market Share in Value by Application (2021-2026) Table 55. Global Pulmonary Surfactant Price by Application (2021-2026) & (US$/unit) Table 56. Global Pulmonary Surfactant Sales by Application (2027-2032) & (k units) Table 57. Global Pulmonary Surfactant Sales Market Share in Volume by Application (2027-2032) Table 58. Global Pulmonary Surfactant Sales by Application (2027-2032) & (US$ Million) Table 59. Global Pulmonary Surfactant Sales Market Share in Value by Application (2027-2032) Table 60. Global Pulmonary Surfactant Price by Application (2027-2032) & (US$/unit) Table 61. North America Pulmonary Surfactant Sales by Application (2021-2026) & (k units) Table 62. North America Pulmonary Surfactant Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Pulmonary Surfactant Sales by Application (2021-2026) & (k units) Table 64. Europe Pulmonary Surfactant Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Pulmonary Surfactant Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Pulmonary Surfactant Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Pulmonary Surfactant Sales by Application (2021-2026) & (k units) Table 68. Latin America Pulmonary Surfactant Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Pulmonary Surfactant Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Pulmonary Surfactant Sales by Application (2021-2026) & (US$ Million) Table 71. Abbott Company Information Table 72. Abbott Business Overview Table 73. Abbott Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Abbott Pulmonary Surfactant Product Portfolio Table 75. Abbott Recent Development Table 76. Nanjing Norris Pharm Technology Company Information Table 77. Nanjing Norris Pharm Technology Business Overview Table 78. Nanjing Norris Pharm Technology Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Nanjing Norris Pharm Technology Pulmonary Surfactant Product Portfolio Table 80. Nanjing Norris Pharm Technology Recent Development Table 81. AbbVie Company Information Table 82. AbbVie Business Overview Table 83. AbbVie Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. AbbVie Pulmonary Surfactant Product Portfolio Table 85. AbbVie Recent Development Table 86. XpressBio Company Information Table 87. XpressBio Business Overview Table 88. XpressBio Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. XpressBio Pulmonary Surfactant Product Portfolio Table 90. XpressBio Recent Development Table 91. Windtree Therapeutics Company Information Table 92. Windtree Therapeutics Business Overview Table 93. Windtree Therapeutics Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Windtree Therapeutics Pulmonary Surfactant Product Portfolio Table 95. Windtree Therapeutics Recent Development Table 96. Tekzima (Noargen) Company Information Table 97. Tekzima (Noargen) Business Overview Table 98. Tekzima (Noargen) Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Tekzima (Noargen) Pulmonary Surfactant Product Portfolio Table 100. Tekzima (Noargen) Recent Development Table 101. Reddot Biotech Company Information Table 102. Reddot Biotech Business Overview Table 103. Reddot Biotech Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Reddot Biotech Pulmonary Surfactant Product Portfolio Table 105. Reddot Biotech Recent Development Table 106. ONY Biotech Company Information Table 107. ONY Biotech Business Overview Table 108. ONY Biotech Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. ONY Biotech Pulmonary Surfactant Product Portfolio Table 110. ONY Biotech Recent Development Table 111. Lyomark Pharma Company Information Table 112. Lyomark Pharma Business Overview Table 113. Lyomark Pharma Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Lyomark Pharma Pulmonary Surfactant Product Portfolio Table 115. Lyomark Pharma Recent Development Table 116. LSBio Company Information Table 117. LSBio Business Overview Table 118. LSBio Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. LSBio Pulmonary Surfactant Product Portfolio Table 120. LSBio Recent Development Table 121. Creative Diagnostics Company Information Table 122. Creative Diagnostics Business Overview Table 123. Creative Diagnostics Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Creative Diagnostics Pulmonary Surfactant Product Portfolio Table 125. Creative Diagnostics Recent Development Table 126. Boehringer Ingelheim Company Information Table 127. Boehringer Ingelheim Business Overview Table 128. Boehringer Ingelheim Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Boehringer Ingelheim Pulmonary Surfactant Product Portfolio Table 130. Boehringer Ingelheim Recent Development Table 131. Biorbyt Company Information Table 132. Biorbyt Business Overview Table 133. Biorbyt Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. Biorbyt Pulmonary Surfactant Product Portfolio Table 135. Biorbyt Recent Development Table 136. Biomatik Company Information Table 137. Biomatik Business Overview Table 138. Biomatik Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 139. Biomatik Pulmonary Surfactant Product Portfolio Table 140. Biomatik Recent Development Table 141. Aviva Systems Biology Company Information Table 142. Aviva Systems Biology Business Overview Table 143. Aviva Systems Biology Pulmonary Surfactant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 144. Aviva Systems Biology Pulmonary Surfactant Product Portfolio Table 145. Aviva Systems Biology Recent Development Table 146. North America Pulmonary Surfactant Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. North America Pulmonary Surfactant Sales by Country (2021-2026) & (k units) Table 148. North America Pulmonary Surfactant Sales Market Share by Country (2021-2026) Table 149. North America Pulmonary Surfactant Sales Forecast by Country (2027-2032) & (k units) Table 150. North America Pulmonary Surfactant Sales Market Share Forecast by Country (2027-2032) Table 151. North America Pulmonary Surfactant Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. North America Pulmonary Surfactant Market Size by Country (2021-2026) & (US$ Million) Table 153. North America Pulmonary Surfactant Market Share by Country (2021-2026) Table 154. North America Pulmonary Surfactant Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. North America Pulmonary Surfactant Market Share Forecast by Country (2027-2032) Table 156. Europe Pulmonary Surfactant Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 157. Europe Pulmonary Surfactant Sales by Country (2021-2026) & (k units) Table 158. Europe Pulmonary Surfactant Sales Market Share by Country (2021-2026) Table 159. Europe Pulmonary Surfactant Sales Forecast by Country (2027-2032) & (k units) Table 160. Europe Pulmonary Surfactant Sales Market Share Forecast by Country (2027-2032) Table 161. Europe Pulmonary Surfactant Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Europe Pulmonary Surfactant Market Size by Country (2021-2026) & (US$ Million) Table 163. Europe Pulmonary Surfactant Market Share by Country (2021-2026) Table 164. Europe Pulmonary Surfactant Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Europe Pulmonary Surfactant Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Pulmonary Surfactant Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Pulmonary Surfactant Sales by Country (2021-2026) & (k units) Table 168. Asia-Pacific Pulmonary Surfactant Sales Market Share by Country (2021-2026) Table 169. Asia-Pacific Pulmonary Surfactant Sales Forecast by Country (2027-2032) & (k units) Table 170. Asia-Pacific Pulmonary Surfactant Sales Market Share Forecast by Country (2027-2032) Table 171. Asia-Pacific Pulmonary Surfactant Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Asia-Pacific Pulmonary Surfactant Market Size by Country (2021-2026) & (US$ Million) Table 173. Asia-Pacific Pulmonary Surfactant Market Share by Country (2021-2026) Table 174. Asia-Pacific Pulmonary Surfactant Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Asia-Pacific Pulmonary Surfactant Market Share Forecast by Country (2027-2032) Table 176. Latin America Pulmonary Surfactant Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 177. Latin America Pulmonary Surfactant Sales by Country (2021-2026) & (k units) Table 178. Latin America Pulmonary Surfactant Sales Market Share by Country (2021-2026) Table 179. Latin America Pulmonary Surfactant Sales Forecast by Country (2027-2032) & (k units) Table 180. Latin America Pulmonary Surfactant Sales Market Share Forecast by Country (2027-2032) Table 181. Latin America Pulmonary Surfactant Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Latin America Pulmonary Surfactant Market Size by Country (2021-2026) & (US$ Million) Table 183. Latin America Pulmonary Surfactant Market Share by Country (2021-2026) Table 184. Latin America Pulmonary Surfactant Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Latin America Pulmonary Surfactant Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Pulmonary Surfactant Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Pulmonary Surfactant Sales by Country (2021-2026) & (k units) Table 188. Middle East and Africa Pulmonary Surfactant Sales Market Share by Country (2021-2026) Table 189. Middle East and Africa Pulmonary Surfactant Sales Forecast by Country (2027-2032) & (k units) Table 190. Middle East and Africa Pulmonary Surfactant Sales Market Share Forecast by Country (2027-2032) Table 191. Middle East and Africa Pulmonary Surfactant Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Middle East and Africa Pulmonary Surfactant Market Size by Country (2021-2026) & (US$ Million) Table 193. Middle East and Africa Pulmonary Surfactant Market Share by Country (2021-2026) Table 194. Middle East and Africa Pulmonary Surfactant Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Middle East and Africa Pulmonary Surfactant Market Share Forecast by Country (2027-2032) Table 196. Key Raw Materials Table 197. Raw Materials Key Suppliers Table 198. Pulmonary Surfactant Distributors List Table 199. Pulmonary Surfactant Customers List Table 200. Research Programs/Design for This Report Table 201. Authors List of This Report Table 202. Secondary Sources Table 203. Primary Sources List of Figures Figure 1. Pulmonary Surfactant Image Figure 2. Global Pulmonary Surfactant Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pulmonary Surfactant Market Size (2021-2032) & (US$ Million) Figure 4. Global Pulmonary Surfactant Sales (2021-2032) & (k units) Figure 5. Synthetic Pulmonary Surfactants Image Figure 6. Global Synthetic Pulmonary Surfactants Sales YoY Growth (2021-2032) & (k units) Figure 7. Animal Derived Surfactants Image Figure 8. Global Animal Derived Surfactants Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Pulmonary Surfactant Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Pulmonary Surfactant Market Share by Type 2025 VS 2032 Figure 11. North America Pulmonary Surfactant Sales Market Share in Volume by Type in 2025 Figure 12. North America Pulmonary Surfactant Sales Market Share in Value by Type in 2025 Figure 13. Europe Pulmonary Surfactant Sales Market Share in Volume by Type in 2025 Figure 14. Europe Pulmonary Surfactant Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Pulmonary Surfactant Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Pulmonary Surfactant Sales Market Share in Value by Type in 2025 Figure 17. Latin America Pulmonary Surfactant Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Pulmonary Surfactant Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Pulmonary Surfactant Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Pulmonary Surfactant Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Pulmonary Surfactant Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 25. laboratory Image Figure 26. Global laboratory Sales YoY Growth (2021-2032) & (k units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Pulmonary Surfactant Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Pulmonary Surfactant Market Share by Application 2025 VS 2032 Figure 31. North America Pulmonary Surfactant Sales Market Share in Volume by Application in 2025 Figure 32. North America Pulmonary Surfactant Sales Market Share in Value by Application in 2025 Figure 33. Europe Pulmonary Surfactant Sales Market Share in Volume by Application in 2025 Figure 34. Europe Pulmonary Surfactant Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Pulmonary Surfactant Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Pulmonary Surfactant Sales Market Share in Value by Application in 2025 Figure 37. Latin America Pulmonary Surfactant Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Pulmonary Surfactant Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Pulmonary Surfactant Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Pulmonary Surfactant Sales Market Share in Value by Application in 2025 Figure 41. North America Pulmonary Surfactant Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Pulmonary Surfactant Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Pulmonary Surfactant Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Pulmonary Surfactant Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Pulmonary Surfactant Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Pulmonary Surfactant Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Pulmonary Surfactant Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Pulmonary Surfactant Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Pulmonary Surfactant Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Pulmonary Surfactant Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Pulmonary Surfactant Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Pulmonary Surfactant Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Pulmonary Surfactant Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Pulmonary Surfactant Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Pulmonary Surfactant Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Pulmonary Surfactant Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Pulmonary Surfactant Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Pulmonary Surfactant Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Pulmonary Surfactant Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Pulmonary Surfactant Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Pulmonary Surfactant Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Pulmonary Surfactant Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Synthetic Pulmonary Surfactants
  • Animal Derived Surfactants
Applications
  • Hospital
  • laboratory
  • Others
Companies covered
  • Abbott
  • Nanjing Norris Pharm Technology
  • AbbVie
  • XpressBio
  • Windtree Therapeutics
  • Tekzima (Noargen)
  • Reddot Biotech
  • ONY Biotech
  • Lyomark Pharma
  • LSBio
  • Creative Diagnostics
  • Boehringer Ingelheim
  • Biorbyt
  • Biomatik
  • Aviva Systems Biology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pulmonary Surfactant Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pulmonary Surfactant Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pulmonary Surfactant Market by Type
  6. 1.3.1 Synthetic Pulmonary Surfactants
  7. 1.3.2 Animal Derived Surfactants
  8. 1.4 Global Pulmonary Surfactant Market Size by Type
  9. 1.4.1 Global Pulmonary Surfactant Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Pulmonary Surfactant Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Pulmonary Surfactant Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Pulmonary Surfactant Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Pulmonary Surfactant Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Pulmonary Surfactant Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Pulmonary Surfactant Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Pulmonary Surfactant Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pulmonary Surfactant Industry Trends
  2. 2.2 Pulmonary Surfactant Industry Drivers
  3. 2.3 Pulmonary Surfactant Industry Opportunities and Challenges
  4. 2.4 Pulmonary Surfactant Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pulmonary Surfactant Revenue (2021-2026)
  2. 3.2 Global Top Players by Pulmonary Surfactant Sales (2021-2026)
  3. 3.3 Global Top Players by Pulmonary Surfactant Price (2021-2026)
  4. 3.4 Global Pulmonary Surfactant Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pulmonary Surfactant Major Company Production Sites & Headquarters
  6. 3.6 Global Pulmonary Surfactant Company, Product Type & Application
  7. 3.7 Global Pulmonary Surfactant Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pulmonary Surfactant Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pulmonary Surfactant Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pulmonary Surfactant Tier 1, Tier 2, and Tier 3
4 Pulmonary Surfactant Regional Status and Outlook
  1. 4.1 Global Pulmonary Surfactant Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pulmonary Surfactant Historic Market Size by Region
  3. 4.2.1 Global Pulmonary Surfactant Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pulmonary Surfactant Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pulmonary Surfactant Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pulmonary Surfactant Forecasted Market Size by Region
  7. 4.3.1 Global Pulmonary Surfactant Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pulmonary Surfactant Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pulmonary Surfactant Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pulmonary Surfactant by Application
  1. 5.1 Pulmonary Surfactant Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 laboratory
  4. 5.1.3 Others
  5. 5.2 Global Pulmonary Surfactant Market Size by Application
  6. 5.2.1 Global Pulmonary Surfactant Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Pulmonary Surfactant Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Pulmonary Surfactant Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Pulmonary Surfactant Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Pulmonary Surfactant Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Pulmonary Surfactant Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Pulmonary Surfactant Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Pulmonary Surfactant Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Abbott
  2. 6.1.1 Abbott Company Information
  3. 6.1.2 Abbott Business Overview
  4. 6.1.3 Abbott Pulmonary Surfactant Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Abbott Pulmonary Surfactant Product Portfolio
  6. 6.1.5 Abbott Recent Developments
  7. 6.2 Nanjing Norris Pharm Technology
  8. 6.2.1 Nanjing Norris Pharm Technology Company Information
  9. 6.2.2 Nanjing Norris Pharm Technology Business Overview
  10. 6.2.3 Nanjing Norris Pharm Technology Pulmonary Surfactant Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Nanjing Norris Pharm Technology Pulmonary Surfactant Product Portfolio
  12. 6.2.5 Nanjing Norris Pharm Technology Recent Developments
  13. 6.3 AbbVie
  14. 6.3.1 AbbVie Company Information
  15. 6.3.2 AbbVie Business Overview
  16. 6.3.3 AbbVie Pulmonary Surfactant Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 AbbVie Pulmonary Surfactant Product Portfolio
  18. 6.3.5 AbbVie Recent Developments
  19. 6.4 XpressBio
  20. 6.4.1 XpressBio Company Information
  21. 6.4.2 XpressBio Business Overview
  22. 6.4.3 XpressBio Pulmonary Surfactant Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 XpressBio Pulmonary Surfactant Product Portfolio
  24. 6.4.5 XpressBio Recent Developments
  25. 6.5 Windtree Therapeutics
  26. 6.5.1 Windtree Therapeutics Company Information
  27. 6.5.2 Windtree Therapeutics Business Overview
  28. 6.5.3 Windtree Therapeutics Pulmonary Surfactant Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Windtree Therapeutics Pulmonary Surfactant Product Portfolio
  30. 6.5.5 Windtree Therapeutics Recent Developments
  31. 6.6 Tekzima (Noargen)
  32. 6.6.1 Tekzima (Noargen) Company Information
  33. 6.6.2 Tekzima (Noargen) Business Overview
  34. 6.6.3 Tekzima (Noargen) Pulmonary Surfactant Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Tekzima (Noargen) Pulmonary Surfactant Product Portfolio
  36. 6.6.5 Tekzima (Noargen) Recent Developments
  37. 6.7 Reddot Biotech
  38. 6.7.1 Reddot Biotech Company Information
  39. 6.7.2 Reddot Biotech Business Overview
  40. 6.7.3 Reddot Biotech Pulmonary Surfactant Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Reddot Biotech Pulmonary Surfactant Product Portfolio
  42. 6.7.5 Reddot Biotech Recent Developments
  43. 6.8 ONY Biotech
  44. 6.8.1 ONY Biotech Company Information
  45. 6.8.2 ONY Biotech Business Overview
  46. 6.8.3 ONY Biotech Pulmonary Surfactant Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 ONY Biotech Pulmonary Surfactant Product Portfolio
  48. 6.8.5 ONY Biotech Recent Developments
  49. 6.9 Lyomark Pharma
  50. 6.9.1 Lyomark Pharma Company Information
  51. 6.9.2 Lyomark Pharma Business Overview
  52. 6.9.3 Lyomark Pharma Pulmonary Surfactant Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Lyomark Pharma Pulmonary Surfactant Product Portfolio
  54. 6.9.5 Lyomark Pharma Recent Developments
  55. 6.10 LSBio
  56. 6.10.1 LSBio Company Information
  57. 6.10.2 LSBio Business Overview
  58. 6.10.3 LSBio Pulmonary Surfactant Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 LSBio Pulmonary Surfactant Product Portfolio
  60. 6.10.5 LSBio Recent Developments
  61. 6.11 Creative Diagnostics
  62. 6.11.1 Creative Diagnostics Company Information
  63. 6.11.2 Creative Diagnostics Business Overview
  64. 6.11.3 Creative Diagnostics Pulmonary Surfactant Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Creative Diagnostics Pulmonary Surfactant Product Portfolio
  66. 6.11.5 Creative Diagnostics Recent Developments
  67. 6.12 Boehringer Ingelheim
  68. 6.12.1 Boehringer Ingelheim Company Information
  69. 6.12.2 Boehringer Ingelheim Business Overview
  70. 6.12.3 Boehringer Ingelheim Pulmonary Surfactant Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Boehringer Ingelheim Pulmonary Surfactant Product Portfolio
  72. 6.12.5 Boehringer Ingelheim Recent Developments
  73. 6.13 Biorbyt
  74. 6.13.1 Biorbyt Company Information
  75. 6.13.2 Biorbyt Business Overview
  76. 6.13.3 Biorbyt Pulmonary Surfactant Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Biorbyt Pulmonary Surfactant Product Portfolio
  78. 6.13.5 Biorbyt Recent Developments
  79. 6.14 Biomatik
  80. 6.14.1 Biomatik Company Information
  81. 6.14.2 Biomatik Business Overview
  82. 6.14.3 Biomatik Pulmonary Surfactant Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Biomatik Pulmonary Surfactant Product Portfolio
  84. 6.14.5 Biomatik Recent Developments
  85. 6.15 Aviva Systems Biology
  86. 6.15.1 Aviva Systems Biology Company Information
  87. 6.15.2 Aviva Systems Biology Business Overview
  88. 6.15.3 Aviva Systems Biology Pulmonary Surfactant Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Aviva Systems Biology Pulmonary Surfactant Product Portfolio
  90. 6.15.5 Aviva Systems Biology Recent Developments
7 North America by Country
  1. 7.1 North America Pulmonary Surfactant Sales by Country
  2. 7.1.1 North America Pulmonary Surfactant Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pulmonary Surfactant Sales by Country (2021-2026)
  4. 7.1.3 North America Pulmonary Surfactant Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pulmonary Surfactant Market Size by Country
  6. 7.2.1 North America Pulmonary Surfactant Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pulmonary Surfactant Market Size by Country (2021-2026)
  8. 7.2.3 North America Pulmonary Surfactant Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pulmonary Surfactant Sales by Country
  2. 8.1.1 Europe Pulmonary Surfactant Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pulmonary Surfactant Sales by Country (2021-2026)
  4. 8.1.3 Europe Pulmonary Surfactant Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pulmonary Surfactant Market Size by Country
  6. 8.2.1 Europe Pulmonary Surfactant Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pulmonary Surfactant Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pulmonary Surfactant Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pulmonary Surfactant Sales by Country
  2. 9.1.1 Asia-Pacific Pulmonary Surfactant Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pulmonary Surfactant Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pulmonary Surfactant Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pulmonary Surfactant Market Size by Country
  6. 9.2.1 Asia-Pacific Pulmonary Surfactant Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pulmonary Surfactant Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pulmonary Surfactant Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pulmonary Surfactant Sales by Country
  2. 10.1.1 South America Pulmonary Surfactant Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pulmonary Surfactant Sales by Country (2021-2026)
  4. 10.1.3 South America Pulmonary Surfactant Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pulmonary Surfactant Market Size by Country
  6. 10.2.1 South America Pulmonary Surfactant Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pulmonary Surfactant Market Size by Country (2021-2026)
  8. 10.2.3 South America Pulmonary Surfactant Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pulmonary Surfactant Sales by Country
  2. 11.1.1 Middle East and Africa Pulmonary Surfactant Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pulmonary Surfactant Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pulmonary Surfactant Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pulmonary Surfactant Market Size by Country
  6. 11.2.1 Middle East and Africa Pulmonary Surfactant Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pulmonary Surfactant Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pulmonary Surfactant Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pulmonary Surfactant Value Chain Analysis
  2. 12.1.1 Pulmonary Surfactant Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pulmonary Surfactant Production Mode & Process
  7. 12.2 Pulmonary Surfactant Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pulmonary Surfactant Distributors
  10. 12.2.3 Pulmonary Surfactant Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst